Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Apolipoprotein E suppresses the type I inflammatory response in vivo.

Ali K, Middleton M, Puré E, Rader DJ.

Circ Res. 2005 Oct 28;97(9):922-7. Epub 2005 Sep 22.

PMID:
16179587
2.

Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.

Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.

Int Immunol. 2007 Mar;19(3):311-20. Epub 2007 Feb 7.

PMID:
17289654
3.

Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.

Romics L Jr, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, Kurt-Jones E, Szabo G.

J Leukoc Biol. 2005 Dec;78(6):1255-64. Epub 2005 Oct 4.

PMID:
16204620
5.
6.

Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands.

Idoyaga J, Moreno J, Bonifaz L.

Cancer Immunol Immunother. 2007 Aug;56(8):1237-50. Epub 2007 Jan 20.

PMID:
17237931
7.

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response.

Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT.

J Neuroimmunol. 2001 Mar 1;114(1-2):107-13.

PMID:
11240021
8.

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.

de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, van Dijk KW, van der Meer JW, Stalenhoef AF.

J Lipid Res. 1999 Apr;40(4):680-5.

9.

Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway.

Srivastava RA, Srivastava N, Averna M, Lin RC, Korach KS, Lubahn DB, Schonfeld G.

J Biol Chem. 1997 Dec 26;272(52):33360-6.

10.

Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.

Westerterp M, Berbée JF, Pires NM, van Mierlo GJ, Kleemann R, Romijn JA, Havekes LM, Rensen PC.

Circulation. 2007 Nov 6;116(19):2173-81. Epub 2007 Oct 22.

PMID:
17967778
11.

Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation.

Calpe-Berdiel L, Escolà-Gil JC, Benítez S, Bancells C, González-Sastre F, Palomer X, Blanco-Vaca F.

Life Sci. 2007 May 1;80(21):1951-6. Epub 2007 Mar 1.

PMID:
17382351
12.

Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.

Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, Zakin MM, Scott-Algara D.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):756-61. Epub 2004 Jan 29.

PMID:
14751811
13.

Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation.

Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, Lin R, De Wit D, Flamand V, Willems F, Goldman M.

Blood. 2006 Feb 1;107(3):1078-84. Epub 2005 Oct 11.

14.

Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.

Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR.

J Am Coll Surg. 2006 Mar;202(3):407-17. Epub 2006 Jan 18.

PMID:
16500244
15.

APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response.

Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT.

J Biol Chem. 2003 Dec 5;278(49):48529-33. Epub 2003 Sep 24.

16.

Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.

Hirata N, Yanagawa Y, Ebihara T, Seya T, Uematsu S, Akira S, Hayashi F, Iwabuchi K, Onoé K.

Mol Immunol. 2008 May;45(10):2734-42. doi: 10.1016/j.molimm.2008.02.010. Epub 2008 Mar 26.

PMID:
18372043
17.

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.

Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Grafenstein Hv, Hong SC, McInerney MF.

Int Immunol. 2006 Jul;18(7):1101-13. Epub 2006 May 25. Erratum in: Int Immunol. 2007 Apr;19(4):581.

PMID:
16728431
19.

Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

Schneider JG, Zhu Y, Coleman T, Semenkovich CF.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2699-706. Epub 2007 Oct 19. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):e12.

PMID:
17951320
20.

Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.

Gómez M, Sanz-González SM, Abu Nabah YN, Lamana A, Sánchez-Madrid F, Andrés V.

Cardiovasc Res. 2009 Jan 1;81(1):197-205. doi: 10.1093/cvr/cvn227. Epub 2008 Aug 14.

Supplemental Content

Support Center